TARS ▼ -0.1% - Tarsus Pharmaceuticals, Inc. $TARS - Tarsus Pharmaceuticals Completes Acquisition of Alkeus Pharmaceuticals, Expanding Leadership in Eye Care Tarsus Pharmaceuticals completed its acquisition of Alkeus Pharmaceuticals, a move intended to expand its footprint in eye care therapeutics. The stock was down 0.1% today, suggesting investors are digesting the deal with measured caution as the company integrates its new asset. 04-SEP-2026 08:38 AM ET